Indications, Issues, and Insights: Integrating EGFR-Targeting Therapy CME
Karen Kelly, MD, Chair; Edward Chu, MD; Hedy L. Kindler, MD; Heinz-Josef Lenz, MD; Thomas J. Lynch, MD Author Information and Disclosures
Release Date: September 24, 2007; Valid for credit through September 24, 2008
| Physicians - maximum of 2.0 AMA PRA Category 1 Credit(s)™ for physicians |
 |
This CME activity is based on transcripts and slides of presentations as delivered by the faculty at the "Indications, Issues, and Insights: Integrating EGFR-Targeting Therapy" symposium held on June 5, 2007 in Chicago, IL.
Contents of This CME Activity
- Welcome and IntroductionKaren Kelly, MDAvailable As: Slides/Audio | Slides/Transcript | Audio
Part 1: EGFR-Targeted Therapy -- Where Is It Now, Where Is It Going?
- How Should Intervention Be Optimized for Metastatic Colorectal Cancer?Heinz-Josef Lenz, MDAvailable As: Slides/Audio | Slides/Transcript | Audio
- Evolving Evidence in Pancreatic CancerHedy Kindler, MDAvailable As: Slides/Audio | Slides/Transcript | Audio
- Is the Treatment Paradigm for NSCLC Changing and if So, How?Thomas Lynch, MDAvailable As: Slides/Audio | Slides/Transcript | Audio
Part 2: Applying the Evidence: A Clinical Perspective
- What Are the Roles of Molecular Markers of Benefit When Selecting Patients for Therapy, and the Clinical Indicators of Response?Edward Chu, MDAvailable As: Slides/Audio | Slides/Transcript | Audio
- Is It Time to Consider the Implications of Sequencing EGFR-Targeted Therapy With Other Targeted Agents?Karen Kelly, MDAvailable As: Slides/Audio | Slides/Transcript | Audio
- Questions and AnswersKaren Kelly, MD; Heinz-Josef Lenz, MD; Hedy Kindler, MD; Thomas Lynch, MD; Edward Chu, MDAvailable As: Slides/Audio | Slides/Transcript | Audio
The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Copyright © 2007 Medical Education Collaborative.
